Chief Executive Officer

Vice President, Global MSAT Drug Substance Biologics Technology and Commercial Products Support

Genentech’s Fenebrutinib Is the First Investigational Med...

Genentech’s Fenebrutinib Is the First Investigational Medicine in Over a Decade That Reduces Disability Progression in Primary Progressive Multiple Sclerosis (PPMS)

As U.S. Life Sciences Market Recovers, “Definite Dichotomy” Among Companies

Genentech awards $300K to Science Center to speed medical innovations to patients

0.8333333134651184

Principal Automation Engineer, BAS/Utilities

Genentech’s Hillsboro Oregon campus serves as a critical hub for emerging cell & gene therapy manufacturing. The Principal Automation Engineer will develop, implement, and optimize automation solutions to support manufacturing, collaborating with cross-functional teams to enhance processes and ensure compliance with regulatory standards.

Principal Automation Engineer, BAS/Utilities (HIT)

Member of the Executive Board - Group CFO

Global Head and Group Vice President, Computational Science and Informatics R&D

Roche's multiple sclerosis drug fenebrutinib meets goal in late-stage trial

Fierce Pharma Asia—Amgen, Kyowa's OX40 divorce; Roche's RNAi deal; Daiichi's ADC cull

GENESIS Biomed closes 2025 with record growth and greater impact on the biomedical ecosystem

From blood tests to orbital labs: Europe’s next generation of cancer tech

Genentech’s Hillsboro Oregon campus is a critical hub for emerging cell & gene therapy manufacturing. As a Principal Automation Engineer, you will develop, implement, and optimize automation solutions, collaborating with cross-functional teams to enhance manufacturing processes and ensure compliance with regulatory standards.

Principal Automation Engineer, Bas Utilities (hit)

Principal Automation Engineer, Bas Utilities (hit) in united states (1000+)

Principal Automation Engineer, BAS/Utilities (HIT)

Principal Automation Engineer, BAS/Utilities (HIT)